Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection.

Pallett, Scott J C; Jones, Rachael; Randell, Paul; Davies, Gary W; Moore, Luke S P

Pallett, Scott J C; Jones, Rachael; Randell, Paul; Davies, Gary W; Moore, Luke S P.

Pallett SJC; Centre of Defence Pathology, Royal Centre for Defence Medicine, Queen Elizabeth Hospital Birmingham, Birmingham B15 2WB, UK; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK. Electronic address: scott.pallett@nhs.net.
Jones R; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Randell P; North West London Pathology, London, UK.
Davies GW; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Moore LSP; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; North West London Pathology, London, UK; Imperial College London, NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, London, UK.

Lancet Infect Dis ; 21(5): 598-599, 2021 05.

Article in English | MEDLINE | ID: covidwho-1039606

Subject(s)

COVID-19; SARS-CoV-2; Humans; Reinfection

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google